cancer biology Archive — Page 2 of 9
-
March 9, 2017
Melanoma study finds new way to enhance targeted therapies
With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy. -
March 2, 2017
Investigators seek new way to define cell identity
Vanderbilt researchers hope their new method to describe cells will be widely adopted and used to generate a “Who’s Who” database of cell types. -
February 20, 2017
Improving therapies for GI tumors
A signaling protein overexpressed in upper gastrointestinal cancers is an attractive therapeutic target. -
December 12, 2016
Vanderbilt earns top rankings, including a No. 1, for successful minority recruitment in master’s and Ph.D. programs
"Diverse: Issues In Higher Education" has ranked Vanderbilt University No. 1 in the country for the number of doctoral degrees awarded to African Americans in the biological and biomedical sciences. -
December 12, 2016
Single-cell analysis of solid tumors
A new method will make it possible to study solid tumors and healthy tissues using mass cytometry. -
November 10, 2016
Links between immune cells and metabolism explored
At the intersection of immunology and metabolism is a burgeoning new field: immunometabolism. It’s an area where Vanderbilt has exceptional strengths, said Jeffrey Rathmell, Ph.D., Cornelius Vanderbilt Professor of Immunobiology. -
November 3, 2016
A DARPP role in gastric cancer
Vanderbilt researchers have discovered a link between Helicobacter pylori infection, inflammation and gastric cancer that could suggest new anti-cancer therapies.